文献
J-GLOBAL ID:201602219245313806
整理番号:16A1271559
世界的ヘパリン汚染危機に対する米国規制当局および薬局方の反応
The US regulatory and pharmacopeia response to the global heparin contamination crisis
著者 (19件):
SZAJEK Anita Y
(US Pharmacopeia, Maryland, USA)
,
MORRIS Tina
(US Pharmacopeia, Maryland, USA)
,
CHESS Edward
(Baxter Healthcare Corp., Illinois, USA)
,
JOHANSEN Kristian
(Sjolundsparken, Hellebaek, DNK)
,
GRATZL Gyoengyi
(Ben Venue Lab., Inc., Ohio, USA)
,
GRAY Elaine
(National Inst. for Biological Standards and Control, Potters Bar, GBR)
,
MULLOY Barbara
(National Inst. for Biological Standards and Control, Potters Bar, GBR)
,
KEIRE David
(US Food and Drug Administration, Missouri, USA)
,
LINHARDT Robert J
(Rensselaer Polytechnic Inst., New York, USA)
,
LIU Jian
(Univ. North Carolina, North Carolina, USA)
,
MULLOY Barbara
(Inst. of Pharmaceutical Sci. King’s Coll. London, London, GBR)
,
NASR Moheb
(R&D, GlaxoSmithKline, Pennsylvania, USA)
,
SHRIVER Zachary
(Massachusetts Inst. of Technol., Massachusetts, USA)
,
TORRALBA Pearle
(Fresenius Kabi USA, Illinois, USA)
,
VISKOV Christian
(Sanofi, Vitry sur Seine, FRA)
,
WILLIAMS Roger
(US Pharmacopeia, Maryland, USA)
,
WOODCOCK Janet
(US Food and Drug Administration, Maryland, USA)
,
AL-HAKIM Ali
(US Food and Drug Administration, Maryland, USA)
,
WORKMAN Wesley
(Pfizer Quality Operations Biotech, Missouri, USA)
資料名:
Nature Biotechnology
(Nature Biotechnology)
巻:
34
号:
6
ページ:
625-630
発行年:
2016年06月
JST資料番号:
H0870A
ISSN:
1087-0156
資料種別:
逐次刊行物 (A)
記事区分:
解説
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)